Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Bold Medicine, Golden Innovation

Xenia Kachur, a graduate student in the Biomedical Engineering Graduate Interdisciplinary Program at the University of Arizona, is working on methods to deliver chemotherapeutic drugs to cancer tissues without harming healthy body cells. Photo credit: Beatriz Verdugo/UANews
Xenia Kachur, a graduate student in the Biomedical Engineering Graduate Interdisciplinary Program at the University of Arizona, is working on methods to deliver chemotherapeutic drugs to cancer tissues without harming healthy body cells. Photo credit: Beatriz Verdugo/UANews

Abstract:
One day, building on the bold work being done by Marek Romanowski and his students, those suffering cancer may be able to receive effective chemotherapy treatment, confident that they will not have to endure the side effects. To a patient facing such treatments, such confidence will be as good as gold.

Bold Medicine, Golden Innovation

Tucson, AZ | Posted on January 31st, 2011

The upside of chemotherapy is that it attacks cancer cells and kills them. The downside - and a steep downside it is - is that it is composed of highly toxic compounds that attack other cells of the body, too, resulting in any number of harmful side effects, from anemia to hair loss to nausea and vomiting.

The question concerning researchers is how do we deliver chemotherapy drugs to the harmful cells and leave the healthy cells alone?

Marek Romanowski, Ph.D. associate professor of biomedical engineering at the UA College of Engineering and member of the BIO5 Institute and the Arizona Cancer Center, and his team might be on to an answer. In a paper authored by primary investigator Sarah Leung, along with Xenia Kachur, Michael Bobnick and Dr. Romanowski, Leung describes an idea that is literally golden.

Chemotherapy drugs are sometimes delivered via microscopic capsules called liposomes made of organic lipids already present in cells. These lipid casings, used in a technique called liposomal therapy, do two things. First, they allow the drugs to more effectively penetrate into cancer cells. At the same time, they keep the body's immune system from eliminating the drugs before they can do their jobs.

The problem is that, as the liposomes degrade, the drugs are potentially released indiscriminately throughout the body. So, how can we force these capsules to release their contents only around those unhealthy tumor cells?

Romanowski and his team are experimenting by coating liposomes with gold, an element which has the property of converting infrared light into heat.

"The heat causes the liposome to become leaky, and then whatever's really concentrated inside can diffuse out through the liposome," says Kachur, a third-year graduate student in the Biomedical Engineering Graduate Interdisciplinary Program.

The idea works because infrared light has the ability to penetrate deeply through the body.

"Once you know where the tumors are, you can go ahead and point your light source toward those areas. Whatever else is left will leave the body or may be slowly released, but not to as high or as toxic of levels as it would be if you just injected the drug systemically," said Leung, a fourth-year graduate student.

One last bonus to the proposed innovation is that the kidneys can naturally filter and eliminate the biodegraded gold nanostructures from the body.

If successful, the gold-coated liposomes being developed at the UA could offer a new way to target delivery of drugs to cancerous regions of the body, non-invasively trigger the drugs' release using infrared light, and provide a way for the body to naturally eliminate the toxic byproducts.

One day, building on the bold work being done by Marek Romanowski and his students, those suffering cancer may be able to receive effective chemotherapy treatment, confident that they will not have to endure the side effects. To a patient facing such treatments, such confidence will be as good as gold.

The paper, "Wavelength-selective Light-induced Release from Plasmon Resonant Liposomes," will appear in the journal Advanced Functional Materials. Learn more about the Department of Biomedical Engineering at bme.engr.arizona.edu/.

####

For more information, please click here

Copyright © University of Arizona

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Bioengineered nanoparticles show promise for fibrinogen manufacture, says Journal of Pharmaceutical Analysis study: Scientists engineer a nanoparticle polymer that can selectively bind to fibrinogen in human plasma, presenting a pathway for improved drug development January 14th, 2022

Photon recycling – The key to high-efficiency perovskite solar cells January 14th, 2022

NSF funds Rice effort to measure, preserve quantum entanglement: Physicist Guido Pagano wins CAREER Award to develop tools for quantum computing January 14th, 2022

Tuning the bonds of paired quantum particles to create dissipationless flow: A tunable platform made from atomically thin materials may help researchers figure out how to create a robust quantum condensate that can flow without losing energy January 14th, 2022

Possible Futures

Towards high-performance organic optoelectronics with better crystallinity at semiconductor interface: Organic molecular interfaces with minimized structural mismatch and spontaneous electron transfer could open doors to high-efficiency optoelectronics January 14th, 2022

New photonic effect could speed drug development: Twisted semiconductor nanostructures convert red light into the twisted blue light in tiny volumes, which may help develop chiral drugs January 14th, 2022

UT Southwestern develops nanotherapeutic to ward off liver cancer January 14th, 2022

The free-energy principle explains the brain January 14th, 2022

Academic/Education

Lifeboat Foundation Guardian Winner Jeff Bezos Donates One Million to Lifeboat Foundation Dream Project Winner Teachers in Space July 30th, 2021

NSF renews Rice-based NEWT Center for water treatment: Partnership primed to introduce game-changing technologies to address global needs October 15th, 2020

Matching Investment Program (MIP) Leverages $140K Empire State Development/NYSTAR Funding to SUNY Poly’s CATN2 to Enable $1.5M in Matching Commitments from Industry Partners: Investment Funds Faculty Research Related to Advanced Materials, Genomics, and Semiconductor Reliability October 18th, 2019

A Quantum Leap: $25M grant makes UC Santa Barbara home to the nation’s first NSF-funded Quantum Foundry, a center for development of materials for quantum information-based technologies September 16th, 2019

Nanomedicine

Bioengineered nanoparticles show promise for fibrinogen manufacture, says Journal of Pharmaceutical Analysis study: Scientists engineer a nanoparticle polymer that can selectively bind to fibrinogen in human plasma, presenting a pathway for improved drug development January 14th, 2022

New photonic effect could speed drug development: Twisted semiconductor nanostructures convert red light into the twisted blue light in tiny volumes, which may help develop chiral drugs January 14th, 2022

UT Southwestern develops nanotherapeutic to ward off liver cancer January 14th, 2022

Preserving the goods: A new technique for isolating intact lysosomes from cell cultures: Scientists advance the study of fragile digestive organelles by developing strategy to rapidly extract them from cells using magnetic nanoparticles January 7th, 2022

Announcements

Nanostructures get complex with electron equivalents: Nanoparticles of two different sizes break away from symmetrical designs January 14th, 2022

New photonic effect could speed drug development: Twisted semiconductor nanostructures convert red light into the twisted blue light in tiny volumes, which may help develop chiral drugs January 14th, 2022

UT Southwestern develops nanotherapeutic to ward off liver cancer January 14th, 2022

The free-energy principle explains the brain January 14th, 2022

Nanobiotechnology

Bioengineered nanoparticles show promise for fibrinogen manufacture, says Journal of Pharmaceutical Analysis study: Scientists engineer a nanoparticle polymer that can selectively bind to fibrinogen in human plasma, presenting a pathway for improved drug development January 14th, 2022

New photonic effect could speed drug development: Twisted semiconductor nanostructures convert red light into the twisted blue light in tiny volumes, which may help develop chiral drugs January 14th, 2022

UT Southwestern develops nanotherapeutic to ward off liver cancer January 14th, 2022

Preserving the goods: A new technique for isolating intact lysosomes from cell cultures: Scientists advance the study of fragile digestive organelles by developing strategy to rapidly extract them from cells using magnetic nanoparticles January 7th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project